|
|
|
This is the preliminary program for the 2009 Joint Statistical
Meetings in Washington, DC.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2009 Program page |
= Applied Session,
= Theme Session,
= Presenter
26
|
Sun, 8/2/09, 2:00 PM - 3:50 PM | CC-201 |
| Bayesian and Adaptive Methods in Clinical Trials - Contributed - Papers | ||
|
Biopharmaceutical Section, Section on Bayesian Statistical Science |
||
| Chair(s): Eunhee Hwang, Wyeth Research | ||
| 2:05 PM |
Nonparametric Bayesian Analysis of Two Adaptive Clinical Trials —  Les Huson, Cmed Research, UK
|
|
| 2:20 PM |
An Objective Bayes Approach to the Multiple Co-Primary Endpoints Problem — Kimberly Crimin, Wyeth Research; Robb Muirhead`, Pfizer Inc.; Andrew Grieve, King's College London
|
|
| 2:35 PM |
A Bayesian Approach for Tailored Therapy — Haoda Fu, Eli Lilly and Company
|
|
| 2:50 PM |
Interim Treatment Selection With a Flexible Selection Margin in Clinical Trials — Yujun Wu, sanofi-aventis; Peng-Liang Zhang, sanofi-aventis
|
|
| 3:05 PM |
Bayesian Phase I/II Drug-Combination Trial Design in Oncology — Ying Yuan, The University of Texas M.D. Anderson Cancer Center; Guosheng Yin, The University of Texas M.D. Anderson Cancer Center
|
|
| 3:20 PM |
Development of a Statistical Methodology to Identify Appropriate Historical Controls for Rare Disease Therapies Using Information Generated from the Peer-Reviewed Scientific Literature — Jessica (Jeongsook) L. Kim, FDA; Jean (Chinying) Wang, FDA; Charles Maplethorpe, FDA
|
|
| 3:35 PM |
Pseudo Maximum Likelihood Approach for Multivariate Longitudinal Data Analysis Subject to Left-Censoring — Ghideon Ghebregiorgis, FDA; Lisa A. Weissfeld, University of Pittsburgh
|
|
|
JSM 2009
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |